Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Emond

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Clinical Genitourinary Cancer|May 29, 2023
Treatment Patterns, Clinical Outcomes, Health Care Resource Utilization and Costs in Older Patients With Metastatic Castration-Resistant Prostate Cancer in the United States: An Analysis of SEER-Medicare DataUmang Swami, Himani Aggarwal, Mo Zhou, et al.
Journal of Comparative Effectiveness Research|November 29, 2022
Real-world weight changes in people with HIV-1 at risk of weight gain (female, Black or Hispanic) switching from integrase strand transfer inhibitorsPrina Donga, Bruno Emond, Aditi Shah, et al.
Infectious Diseases and Therapy|August 2, 2022
Association Between Weight Gain and the Incidence of Cardiometabolic Conditions Among People Living with HIV-1 at High Risk of Weight Gain Initiated on Antiretroviral TherapyGrace A McComsey, Bruno Emond, Aditi Shah, et al.
Journal of Managed Care & Specialty Pharmacy|July 11, 2022
Clinical and economic burden of tumor lysis syndrome among patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: A real-world US retrospective studyKerry A Rogers, Xiaoxiao Lu, Bruno Emond, et al.
BMC Pulmonary Medicine|May 14, 2026
Real-world treatment and healthcare resource utilization patterns among patients with advanced non-small cell lung cancer treated with amivantamab: a retrospective study using insurance claims dataDavid Waterhouse, Iris Lin, Laura Morrison, et al.
Journal of Managed Care & Specialty Pharmacy|November 21, 2019
Long-Term Benefits of Rapid Antiretroviral Therapy Initiation in Reducing Medical and Overall Health Care Costs Among Medicaid-Covered Patients with Human Immunodeficiency VirusCarmela Benson, Bruno Emond, Hela Romdhani, et al.
Pharmacoeconomics - Open|August 9, 2018
Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone PalmitateBruno Emond, Kruti Joshi, Antoine C El Khoury, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 31, 2023
Weight and BMI Changes Following Initiation of Emtricitabine/Tenofovir Alafenamide Co-Formulated with Darunavir or Co-Administered with Dolutegravir in Overweight or Obese, ART-Naïve People Living with HIV-1Prina Donga, Bruno Emond, Carmine Rossi, et al.
Journal of Managed Care & Specialty Pharmacy|June 8, 2018
Risk Factors, Health Care Resource Utilization, and Costs Associated with Nonadherence to Antiretrovirals in Medicaid-Insured Patients with HIVKeith Dunn, Marie-Hélène Lafeuille, Xiaolong Jiao, et al.
Current Medical Research and Opinion|December 18, 2018
Real-world outcomes post-transition to once-every-3-months paliperidone palmitate in patients with schizophrenia within US commercial plansBruno Emond, Antoine C El Khoury, Charmi Patel, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Clinical Genitourinary Cancer|May 29, 2023
Treatment Patterns, Clinical Outcomes, Health Care Resource Utilization and Costs in Older Patients With Metastatic Castration-Resistant Prostate Cancer in the United States: An Analysis of SEER-Medicare DataUmang Swami, Himani Aggarwal, Mo Zhou, et al.
Journal of Comparative Effectiveness Research|November 29, 2022
Real-world weight changes in people with HIV-1 at risk of weight gain (female, Black or Hispanic) switching from integrase strand transfer inhibitorsPrina Donga, Bruno Emond, Aditi Shah, et al.
Infectious Diseases and Therapy|August 2, 2022
Association Between Weight Gain and the Incidence of Cardiometabolic Conditions Among People Living with HIV-1 at High Risk of Weight Gain Initiated on Antiretroviral TherapyGrace A McComsey, Bruno Emond, Aditi Shah, et al.
Journal of Managed Care & Specialty Pharmacy|July 11, 2022
Clinical and economic burden of tumor lysis syndrome among patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: A real-world US retrospective studyKerry A Rogers, Xiaoxiao Lu, Bruno Emond, et al.
BMC Pulmonary Medicine|May 14, 2026
Real-world treatment and healthcare resource utilization patterns among patients with advanced non-small cell lung cancer treated with amivantamab: a retrospective study using insurance claims dataDavid Waterhouse, Iris Lin, Laura Morrison, et al.
Journal of Managed Care & Specialty Pharmacy|November 21, 2019
Long-Term Benefits of Rapid Antiretroviral Therapy Initiation in Reducing Medical and Overall Health Care Costs Among Medicaid-Covered Patients with Human Immunodeficiency VirusCarmela Benson, Bruno Emond, Hela Romdhani, et al.
Pharmacoeconomics - Open|August 9, 2018
Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone PalmitateBruno Emond, Kruti Joshi, Antoine C El Khoury, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 31, 2023
Weight and BMI Changes Following Initiation of Emtricitabine/Tenofovir Alafenamide Co-Formulated with Darunavir or Co-Administered with Dolutegravir in Overweight or Obese, ART-Naïve People Living with HIV-1Prina Donga, Bruno Emond, Carmine Rossi, et al.
Journal of Managed Care & Specialty Pharmacy|June 8, 2018
Risk Factors, Health Care Resource Utilization, and Costs Associated with Nonadherence to Antiretrovirals in Medicaid-Insured Patients with HIVKeith Dunn, Marie-Hélène Lafeuille, Xiaolong Jiao, et al.
Current Medical Research and Opinion|December 18, 2018
Real-world outcomes post-transition to once-every-3-months paliperidone palmitate in patients with schizophrenia within US commercial plansBruno Emond, Antoine C El Khoury, Charmi Patel, et al.
Pageof 8